Articles | EuroIntervention

10.4244/EIJV5I2A34 • Jun 30, 2009

Impact of stent length on restenosis in patients with acute myocardial infarction treated with primary percutaneous coronary intervention: analysis based on data from the Trial to Assess the Use of the Cypher Stent in Acute Myocardial Infarction Treated with Balloon Angioplasty (TYPHOON)

Rozenman Y, Witzling V, Tamari I, Turkisher V, Kriviski M, Bode C, Henry P, Teiger E, Cebrian A, Stoll H, Spaulding C

free

10.4244/EIJV5I2A35 • Jun 30, 2009

Reproducibility of quantitative optical coherence tomography for stent analysis

Gonzalo N, Garcia-Garcia H, Serruys PW, Commissaris K, Bezerra H, Gobbens P, Costa M, Regar E

free

10.4244/EIJV5I2A36 • Jun 30, 2009

The ProLimus trial: a prospective, non-randomised, multicentre trial to evaluate the safety and clinical performance of the pimecrolimus eluting stent system (ProGenic)

Verheye S, Sarno G, Muller R, Birkemeyer R, Vrints C, Jung W, Agostoni P, van Langenhove G, Haine S, Willems T, Haude M, Grube E, Wijns W

free

10.4244/EIJV5I2A37 • Jun 30, 2009

Prognostic heterogeneity among patients with chronic stable coronary disease: determinants of long-term mortality after treatment with percutaneous intervention

Lemos P, Campos C, FalcÃ£o J, Ribeiro E, Perin M, Kajita L, Filho E, da Gama M, Horta P, Marchiori G, Spadaro A, Martinez E

free

• Jun 30, 2009

Rapid pacing rotational angiography with three-dimensional reconstruction: use and benefits in structural heart disease interventions

Noble S, Miro J, Yong G, Bonan R, Tardif J-C, Ibrahim R

free

• Jun 30, 2009

Long-term results of immunosuppressive oral prednisone after coronary angioplasty in non-diabetic patients with elevated C-reactive protein levels

Ferrero V, Tomai F, Versaci F, Feola M, Proietti I, Rognoni A, Ghini A, Gaspardone A, Vacca G, De Luca L, Vassanelli C, Ribichini F

free

10.4244/EIJV5I2A40 • Jun 30, 2009

Percutaneous coronary intervention with oral sirolimus and bare metal stents has comparable safety and efficacy to treatment with drug eluting stents, but with significant cost saving: long-term follow-up results from the randomised, controlled ORAR III (Oral Rapamycin in ARgentina) study Alfredo E.

Rodriguez A, Maree A, Tarragona S, Fernandez-Pereira C, Santaera O, Granillo R, Rodríguez-Granillo G, Russo-Felssen M, Kukreja N, Antoniucci D, Palacios I, Serruys PW

free

10.4244/EIJV5I2A41 • Jun 30, 2009

Use of the Heartrail II catheter as a distal stent delivery device; an extended case series

Mamas MA, Eichhofer E, Hendry C, El-Omar M, Clarke B, Neyses L, Fath-Ordoubadi F, Fraser D

free

10.4244/EIJV5I2A42 • Jun 30, 2009

Impact of dye injection on intracoronary pressure

Stoel M, Kandhai-Ragunath J, van Houwelingen K, von Birgelen C

free

10.4244/EIJV5I2A43 • Jun 30, 2009

Coronary stenting in warfarin treated patients

Zahger D, Ilia R

free

• May 19, 2009

Foreword

Escaned J, Macaya C, Serruys PW

free

• May 19, 2009

Secondary coronary revascularisation: an emerging issue

Escaned J

free

• May 19, 2009

Meditations on secondary revascularisation in the aftermath of the SYNTAX trial

Garg S, Serruys PW

free

• May 19, 2009

Does prior PCI influence the clinical outcome of CABG?

Taggart D

free

• May 19, 2009

Assessment of patients with previous CABG

Maroto L, Silva J, Rodríguez J

free